Dr. Mayank Goyal

Biography

Mayank Goyal is a Professor in the Department of Radiology and Clinical Neurosciences at the University of Calgary. He also holds the Heart and Stroke Foundation Chair in Stroke Research. He is the Director of Imaging and Endovascular treatment at the Calgary Stroke Program. Dr. Goyal’s passion and main research interest is acute stroke imaging, workflow and intervention. With 285 peer-review manuscripts (including NEJM, Lancet Neurology, Radiology, Circulation, ANJR, Stroke), >35 editorials and opinion pieces, over 300 abstracts and >200 invite lectureships, Mayank has been an integral contributor in furthering the field of Stroke intervention research. He was one of the Principal Investigators in two global multi-centric trials in the field: ESCAPE and SWIFT PRIME (both published in NEJM). He was also the core-lab for the REVASCAT trial (published in NEJM) and is the Co-PI of a CIHR funded study called PROVE IT. Dr. Goyal is world renowned for his ground-breaking work in efficiency and workflow in acute stroke intervention. He has extensively traveled across the world as a consequence of this expertise and has been one of the key components in transforming the Calgary Stroke Program into a world renowned acute stroke programs in the world. In addition, Mayank is an innovator and is always thinking of solutions to problems. Conceptualizing a new way of imaging in acute stroke called multiphase CT angiography, his ground-breaking innovation subsequently became the basis for the PROVE IT study (a study doing a head-to-head comparison between multiphase CTA and CT perfusion) and was implemented globally as part of the ESCAPE study. Initial results and feedback suggest that the technique is extremely useful and saves on average 20-minutes in acute stroke treatment (published in Radiology). With the success of ESCAPE and SWIFT PRIME, Dr. Goyal has been an integral part of changing stroke care across the world and helping thousands of patients achieve a good outcome from what is otherwise a devastating disease. Leading a meta-analysis (HERMES) consisting of the recent 7 positive trials published in NEJM, Dr. Goyal’s first paper (as first author) was recently published in Lancet. The second paper, analyzing the impact of time on outcome, was recently published in JAMA (Mayank as co-first author). Dr. Goyal continues to push the boundaries of stroke research, Co-PI to a newly published trial (in Lancet) called ESCAPE-NA1 (testing the added usefulness of neuroprotection in addition to endovascular stroke therapy) as well as of a worldwide study of understanding variance of decision making in acute stroke (UNMASK EVT). A citation index of 39177, an h-index of 73 and an i10 index of 380 (google scholar, Jan 2021) are testimony to Dr. Goyal’s vast contribution and influence in the world of Stroke research. Bestowed with several honours and awards including the Outstanding Contributions in Research Award (American Society of Neuroradiology, 2020), and the Lifetime Contribution Award (Canadian Association of Radiology, 2018), Mayank continues to weave and expand the worldwide teaching network in the fields of Stroke imaging and intervention. Mayank enjoys teaching and successfully runs a yearly stroke course called 5T (where the 5Ts stand for: teamwork, transport, training, technique and technology).